Cargando…
EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic
Autores principales: | Dreyling, Martin, Aurer, Igor, Federico, Massimo, Jerkeman, Mats, Kersten, Marie Jose, Linton, Kim, Mey, Ulrich, Tilly, Herve, Buske, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051991/ https://www.ncbi.nlm.nih.gov/pubmed/33880434 http://dx.doi.org/10.1097/HS9.0000000000000529 |
Ejemplares similares
-
Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
por: Dimopoulos, Meletios A., et al.
Publicado: (2021) -
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer
por: Falanga, Anna, et al.
Publicado: (2022) -
EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell Lymphoma
por: Linton, Kim, et al.
Publicado: (2020) -
Double Hit Lymphoma Diagnosis and Treatment in Europe—A Cross-Sectional Survey of Clinical Practice by the EHA Lymphoma Working Party (EHA LyG)
por: Aurer, Igor, et al.
Publicado: (2020) -
EHA Endorsement of ESMO Clinical Practice Guidelines for Marginal Zone Lymphomas
por: Ladetto, Marco, et al.
Publicado: (2020)